Inositol administration reduces oxidative stress in erythrocytes of patients with polycystic ovary syndrome

European Journal of Endocrinology

Volumn 166, Issue 4, 2012, Pages 703-710

  Donà, Gabriella ^a   Sabbadin, Chiara ^a   Fiore, Cristina ^a   Bragadin, Marcantonio ^b   Giorgino, Francesco L ^c   Ragazzi, Eugenio ^a   Clari, Giulio ^a   Bordin, Luciana ^a   Armanini, Decio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b CA' FOSCARI UNIVERSITY OF VENICE   (Italy)

^c Associazione Ginecologi Extra Ospedalieri (AGEO)   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; GLUCOSE; GLUTATHIONE; GLUTATHIONYLATED PROTEIN; INOSITOL; INSULIN; MEMBRANE PROTEIN; PLACEBO; TESTOSTERONE; TYROSINE; UNCLASSIFIED DRUG;

ADULT; ANDROSTENEDIONE BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; ERYTHROCYTE MEMBRANE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HORMONE METABOLISM; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; OVARY POLYCYSTIC DISEASE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SYSTOLIC BLOOD PRESSURE; TESTOSTERONE BLOOD LEVEL;

ADULT; BLOOD GLUCOSE; DOWN-REGULATION; DRUG ADMINISTRATION SCHEDULE; ERYTHROCYTE COUNT; ERYTHROCYTES; FEMALE; HUMANS; INOSITOL; INSULIN; INSULIN RESISTANCE; OXIDATIVE STRESS; PLACEBOS; POLYCYSTIC OVARY SYNDROME; YOUNG ADULT;

EID: 84859416974     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0840     Document Type: Article

References (48)

1. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED & Bartzis MI. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. Journal of Clinical Endocrinology and Metabolism 1999 84 4006-4011. (doi:10.1210/jc.84. 11.4006)
2. Nestler JE. Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications. Seminars in Reproductive Endocrinology 1997 15 111-122. (doi:10.1055/s-2007-1016294)
3. Apridonidze T, Essah PA, Iuorno MJ & Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2005 90 1929-1935. (doi:10.1210/jc.2004-1045)
4. Romero G & Larner J. Insulin mediators and the mechanism of insulin action. Advances in Pharmacology 1993 24 21-50. (doi:10.1016/S1054-3589(08) 60932-1)
5. Saltiel AR. Second messengers of insulin action. Diabetes Care 1990 13 244-256. (doi:10.2337/diacare.13.3.244)
6. Nestler JE, Jakubowicz DJ, Reamer P, Gunn RD & Allan G. Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. New England Journal of Medicine 1999 340 1314-1320. (doi:10.1056/ NEJM199904293401703)
7. Iuorno MJ, Jakubowicz DJ, Baillargeon JP, Dillon P, Gunn RD, Allan G & Nestler JE. Effects of D-chiro-inositol in lean women with the polycystic ovary syndrome. Endocrine Practice 2002 8 417-423. (Pubitemid 35423128)
8. Gerli S, Mignosa M & Di Renzo GC. Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial. European Review for Medical and Pharmacological Sciences 2003 7 151-159. (Pubitemid 38659930)
9. Baillargeon JP, Diamanti-Kandarakis E, Ostlund RE Jr, Apridonidze T, Iuorno MJ & Nestler JE. Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome. Diabetes Care 2006 29 300-305. (doi:10.2337/diacare.29.02.06.dc05-1070)
10. Baillargeon JP, Nestler JE, Ostlund RE, Apridonidze T & Diamanti-Kandarakis E. Greek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolism. Human Reproduction 2008 23 1439-1446. (doi:10.1093/humrep/den097)
11. Gonzàlez F, Rote NS, Minium J & Kirwan JP. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2006 91 336-340. (doi:10.1210/jc.2005-1696)
12. Victor VM, Rocha M, Bañuls C, Sanchez-Serrano M, Sola E, Gomez M & Hernandez-Mijares A. Mitochondrial complex I impairment in leukocytes from polycystic ovary syndrome patients with insulin resistance. Journal of Clinical Endocrinology and Metabolism 2009 94 3505-3512. (doi:10.1210/jc.2009-0466)
13. Sabuncu T, Vural H, Harma M & Harma M. Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clinical Biochemistry 2001 34 407-413. (doi:10.1016/S0009-9120(01)00245-4)
14. Stadtman ER & Levine RL. Protein oxidation. Annals of the New York Academy of Sciences 2000 899 191-208. (doi:10.1111/j.1749-6632.2000.tb06187.x)
15. Pacifici RE & Davies KJ. Protein degradation as an index of oxidative stress. Methods in Enzymology 1990 186 485-502. (doi:10.1016/0076-6879(90) 86143-J)
16. Bordin L, Quartesan S, Zen F, Vianello F & Clari G. Band 3 Tyr-phosphorylation in human erythrocytes from non-pregnant and pregnant women. Biochimica et Biophysica Acta 2006 1758 611-619. (doi:10.1016/j.bbamem.2006.03. 009)
17. Fiore C, Bordin L, Pellati D, Armanini D & Clari G. Effect of glycyrrhetinic acid on membrane band 3 in human erythrocytes. Archives of Biochemistry and Biophysics 2008 479 46-51. (doi:10.1016/j.abb.2008.08.011)
18. Bordin L, Fiore C, Zen F, Coleman MD, Ragazzi E & Clari G. Dapsone hydroxylamine induces premature removal of human erythrocytes by membrane reorganization and antibody binding. British Journal of Pharmacology 2010 161 1186-1199. (doi:10.1111/j.1476-5381.2010.00962.x)
19. Salvemini D & Cuzzocrea S. Oxidative stress in septic shock and disseminated intravascular coagulation. Free Radical Biology &Medicine 2002 33 1173-1185. (doi:10.1016/S0891-5849(02)00961-9)
20. Bordin L, Ion-Popa F, Brunati AM, Clari G & Low PS. Effector-induced Syk-mediated phosphorylation in human erythrocytes. Biochimica et Biophysica Acta 2005 1745 20-28. (doi:10.1016/j.bbamcr.2004.12.010)
21. Bordin L, Zen F, Ion-Popa F, Barbetta M, Baggio B & Clari G. Band 3 Tyr-phosphorylation in normal and glucose-6-phosphate dehydrogenase-deficient human erythrocytes. Molecular Membrane Biology 2005 22 411-420. (doi:10.1080/09687860500233679)
22. Bordin L, Fiore C, Donà G, Andrisani A, Ambrosini G, Faggian D, Plebani M, Clari G & Armanini D. Evaluation of erythrocyte band 3 phosphotyrosine level, glutathione content, CA-125, and human epididymal secretory protein E4 as combined parameters in endometriosis. Fertility and Sterility 2010 94 1616-1621. (doi:10.1016/j.fertnstert.2009.10.038)
23. Clements RS Jr & Darnell B. Myo-inositol content of common foods: development of a high-myo-inositol diet. American Journal of Clinical Nutrition 1980 33 1954-1967.
24. Horbowicz M, Brenac P & Obendorf RL. Fagopyritol B1, O-alpha-D-galactopyranosyl-(1 → 2)-D-chiro-inositol, a galactosyl cyclitol in maturing buckwheat seeds associated with desiccation tolerance. Planta 1998 205 1-11. (doi:10.1007/s004250050290)
25. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility 2004 81 19-25.
26. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF &Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419. (doi:10.1007/BF00280883)
27. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Analytical Biochemistry 1969 27 502-522. (doi:10.1016/0003- 2697(69)90064-5)
28. Di Simplicio P, Cacace MG, Lusini L, Giannerini F, Giustarini D &Rossi R. Role of protein -SH groups in redox homeostasis - the erythrocyte as a model system. Archives of Biochemistry and Biophysics 1998 355 145-152. (doi:10.1006/abbi.1998.0694)
29. Economou F, Xyrafis X, Livadas S, Androulakis II, Argyrakopoulou G, Christakou CD, Kandaraki E, Palioura E &Diamanti-Kandarakis E. In overweight/obese but not in normal-weight women, polycystic ovary syndrome is associated with elevated liver enzymes compared to controls. Hormones 2009 8 199-206.
30. Takeuchi T, Tsutsumi O & Taketani Y. Abnormal response of insulin to glucose loading and assessment of insulin resistance in non-obese patients with polycystic ovary syndrome. Gynecological Endocrinology 2008 24 385-391. (doi:10.1080/09513590802173584)
31. Dunaif A, Segal KR, Futterweit W & Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989 38 1165-1174. (doi:10.2337/diabetes.38.9.1165)
32. Diamanti-Kandarakis E, Alexandraki K, Bergiele A, Kandarakis H, Mastorakos G & Aessopos A. Presence of metabolic risk factors in non-obese PCOS sisters: evidence of heritability of insulin resistance. Journal of Endocrinological Investigation 2004 27 931-936. (Pubitemid 40124188)
33. Macut D, Simic T, Lissounov A, Pljesa-Ercegovac M, Bozic I, Djukic T, Bjekic-Macut J, Matic M, Petakov M, Suvakov S, Damjanovic S & Savic-Radojevic A. Insulin resistance in non-obese women with polycystic ovary syndrome: relation to byproducts of oxidative stress. Experimental and Clinical Endocrinology & Diabetes 2011 119 451-455. (doi:10.1055/s-0031-1279740)
34. 2-generating system that is activated by insulin via a mechanism bypassing the receptor kinase. Journal of Clinical Investigation 1992 89 1006-1013. (doi:10.1172/JCI115641)
35. Rifici VA, Schneider SH & Khachadurian AK. Stimulation of low-density lipoprotein oxidation by insulin and insulin like growth factor I. Atherosclerosis 1994 107 99-108. (doi:10.1016/0021-9150(94)90145-7)
36. Galvan AQ, Muscelli E, Catalano C, Natali A, Sanna G, Masoni A, Bernardini B, Barsacchi R & Ferrannini E. Insulin decreases circulating vitamin E levels in humans. Metabolism: Clinical and Experimental 1996 45 998-1003. (doi:10.1016/S0026-0495(96)90270-X)
37. Brunati AM, Bordin L, Clari G, James P, Quadroni M, Baritono E, Pinna LA & Donella-Deana A. Sequential phosphorylation of protein band 3 by Syk and Lyn tyrosine kinases in intact human erythrocytes: identification of primary and secondary phosphorylation sites. Blood 2000 96 1550-1557. (Pubitemid 30658490)
38. Bordin L, Brunati AM, Donella-Deana A, Baggio B, Toninello A &Clari G. Band 3 is an anchor protein and a target for SHP-2 tyrosine phosphatase in human erythrocytes. Blood 2002 100 276-282. (doi:10.1182/blood.V100.1.276)
39. Carlomagno G, Unfer V & Roseff S. The D-chiro-inositol paradox in the ovary. Fertility and Sterility 2011 95 2515-2516. (doi:10.1016/j.fertnstert. 2011.05.027)
40. Carlomagno G & Unfer V. Inositol safety: clinical evidences. European Review for Medical and Pharmacological Sciences 2011 15 931-936.
41. Di Daniel E, Kew JN & Maycox PR. Investigation of the H(+)-myoinositol transporter (HMIT) as a neuronal regulator of phosphoinositide signalling. Biochemical Society Transactions 2009 37 1139-1143. (doi:10.1042/BST0371139)
42. Larner J. Mediators of postreceptor action of insulin. American Journal of Medicine 1983 74 38-51. (doi:10.1016/0002-9343(83)90653-8)
43. Larner J. Insulin-signaling mechanisms. Lessons from the old testament of glycogen metabolism and the new testament of molecular biology. Diabetes 1988 37 262-275.
44. Larner J, Huang LC, Suzuki S, Tang G, Zhang C, Schwartz CFW, Romero G, Luttrell L & Kennington AS. Insulin mediators and the control of pyruvate dehyrogenase complex. Annals of the New York Academy of Sciences 1989 573 297-305. (doi:10.1111/j.1749-6632.1989.tb15006.x)
45. Jones DR & Varela-Nieto I. The role of glycosyl-phosphatidylinositol in signal transduction. International Journal of Biochemistry & Cell Biology 1998 30 313-326. (doi:10.1016/S1357-2725(97)00144-1)
46. Cheang KI, Baillargeon JP, Essah PA, Ostlund RE Jr, Apridonize T, Islam L & Nestler JE. Insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome. Metabolism: Clinical and Experimental 2008 10 1390-1397. (doi:10.1016/j.metabol.2008.05.008)
47. Papaleo E, Unfer V, Baillargeon JP & Chiu TT. Contribution of myoinositol to reproduction. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2009 147 120-123. (doi:10.1016/j.ejogrb.2009.09.008)
48. Cohen J. Statistical Power Analysis for the Behavioral Sciences. New York: Academic Press, 1977.